CHROMEDX ANNOUNCES COMPLETION OF HEMOPALMTM PROTOTYPE CARTRIDGE
TORONTO, ONTARIO -- (September 4, 2015) - ChroMedX Corp. (the Company) (CSE: CHX, OTC: MNLIF, Frankfurt: EIY2), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report the completion of the HemoPalmT ...
↧
